A major university and a biotech company in Korea collaborate to create four adorable puppies, clones of a black labrador prized for her ability to detect cancer.

Scientists from the Kimmel Cancer Center report it may be possible to stop the progression of prostate cancer by blocking a signaling protein called Stat3.

Physicians from Uganda and Connecticut discuss abstinence, condoms, cancer, HIV, and snow (plus a few other interesting topics) on Yale Cancer Center Answers.

A study led by the Fred Hutchinson Cancer Research Center suggests that tumors with intact P53 genes may respond better to prostate cancer treatments designed to target insulin-like growth factor 1 receptors (IGF-1R). Fred Hutchinson’s findings could have an important impact on more than a dozen clinical trials currently being conducted to test IGF-1R inhibitors. [...]

The US Department of Health and Human Services’ Agency for Healthcare Research and Quality (AHRQ) and the Ad Council have launched a national ad campaign encouraging men over 40 to take an active role in their own health care. The Real Men Wear Gowns campaign, which was created pro bono by McCann Erickson Detroit, includes [...]

A study led by the Methodist Hospital Research Institute indicates extracts from a tropical fungus called Phellinus linteus may combat breast cancer. Methodist Hospital’s results add to previous research suggesting the yellow mushroom is also effective for slowing lung, prostate and skin cancers. Phellinus linteus grows on the bark of mulberry trees and has been [...]

Research led by the Duke University Medical Center is causing doctors to reconsider the results of prostate-specific antigen (PSA) blood tests done on their overweight patients. Duke’s study of 535 men has revealed that males classified as overweight and obese based on their Body Mass Index have deceptively low concentrations of PSA in their bloodstreams [...]

A study led by the Harvard School of Medicine provides evidence that targeted chemotherapies commonly used to treat glioblastoma may do more harm than good for some patients. Glioblastoma is a rare form of brain cancer with a poor survival rate. STAT3 inhibitors are one of the few therapies available to treat the disease, but [...]

A study released by drug manufacturer GTx, Inc (NASDAQ: GTXI) indicates a new version of an old drug called toremifene helps reduce some of the side effects experienced by prostate cancer patients being treated with androgen-deprivation therapy (ADT). ADT, also known as androgen suppression therapy or AST, is a hormone therapy designed to block the [...]

Researchers from the Dana-Farber Cancer Institute and the University of Connecticut found that prostate cancer patients taking low dose aspirin to prevent heart attacks and strokes had a lower survival rate than those men who didn’t follow an aspirin regimen. The scientists attribute the difference in mortality rates to the interruption of hormone therapies used [...]